blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2396659

EP2396659 - RBM3 PROTEIN IN TESTICULAR CANCER DIAGNOSTICS AND PROGNOSTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.09.2013
Database last updated on 29.06.2024
Most recent event   Tooltip01.07.2016Lapse of the patent in a contracting state
New state(s): IS		published on 03.08.2016  [2016/31]
Applicant(s)For all designated states
Atlas Antibodies AB
AlbaNova Universitetscentrum
106 91 Stockholm / SE
[2011/51]
Inventor(s)01 / JIRSTRÖM, Karin
Scaniagatan 26
S-216 18 Limhamn / SE
02 / EBERHARD, Jakob
Styrbjörn starkes gränd 13
S-224 77 Lund / SE
 [2011/51]
Representative(s)Wirén, Anders, et al
Kransell & Wennborg KB
P.O. Box 27834
115 93 Stockholm / SE
[N/P]
Former [2011/51]Wirén, Anders, et al
Kransell & Wennborg KB P.O. Box 27834
115 93 Stockholm / SE
Application number, filing date10704927.216.02.2010
WO2010EP51935
Priority number, dateWO2009SE0009116.02.2009         Original published format: PCT/SE2009/000091
EP2009015808416.04.2009         Original published format: EP 09158084
US20090169963P16.04.2009         Original published format: US 169963 P
EP2009016784713.08.2009         Original published format: EP 09167847
US20090233769P13.08.2009         Original published format: US 233769 P
WO2009EP6741917.12.2009         Original published format: PCT/EP2009/067419
[2011/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010092187
Date:19.08.2010
Language:EN
[2010/33]
Type: A1 Application with search report 
No.:EP2396659
Date:21.12.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 19.08.2010 takes the place of the publication of the European patent application.
[2011/51]
Type: B1 Patent specification 
No.:EP2396659
Date:21.11.2012
Language:EN
[2012/47]
Search report(s)International search report - published on:EP19.08.2010
ClassificationIPC:G01N33/574, G01N33/68, C07K14/47
[2012/11]
CPC:
G01N33/689 (EP,US); A61P35/00 (EP); C07K14/4748 (EP,US);
G01N33/5743 (EP,US)
Former IPC [2011/51]G01N33/574, G01N33/68
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/51]
TitleGerman:PROTEIN RBM3 ZUR DIAGNOSE UND PROGNOSE VON HODENKREBS[2012/11]
English:RBM3 PROTEIN IN TESTICULAR CANCER DIAGNOSTICS AND PROGNOSTICS[2011/51]
French:PROTÉINE RBM3 UTILISÉE DANS LE DIAGNOSTIC ET LE PRONOSTIC DU CANCER DES TESTICULES[2011/51]
Former [2011/51]RBM3-PROTEIN BEI DER DIAGNOSTIK UND PROGNOSTIK VON HODENKREBS
Entry into regional phase31.08.2011National basic fee paid 
31.08.2011Designation fee(s) paid 
31.08.2011Examination fee paid 
Examination procedure31.08.2011Amendment by applicant (claims and/or description)
31.08.2011Examination requested  [2011/51]
09.01.2012Despatch of a communication from the examining division (Time limit: M04)
31.01.2012Reply to a communication from the examining division
14.03.2012Communication of intention to grant the patent
03.07.2012Fee for grant paid
03.07.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.01.2012
Opposition(s)22.08.2013No opposition filed within time limit [2013/44]
Fees paidRenewal fee
13.02.2012Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.02.2010
AT21.11.2012
BE21.11.2012
CY21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IS21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MK21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
SM21.11.2012
TR21.11.2012
LU16.02.2013
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
[2016/31]
Former [2015/34]HU16.02.2010
AT21.11.2012
BE21.11.2012
CY21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MK21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
SM21.11.2012
TR21.11.2012
LU16.02.2013
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2015/32]AT21.11.2012
BE21.11.2012
CY21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MK21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
SM21.11.2012
TR21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2015/30]AT21.11.2012
BE21.11.2012
CY21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
SM21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2015/24]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
SM21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2014/32]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
MT21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2014/09]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
HR31.07.2013
Former [2013/42]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
MC28.02.2013
ES04.03.2013
PT21.03.2013
Former [2013/37]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
IT21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
RO21.11.2012
SI21.11.2012
SK21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
ES04.03.2013
PT21.03.2013
Former [2013/35]AT21.11.2012
BE21.11.2012
CZ21.11.2012
EE21.11.2012
FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
SI21.11.2012
SK21.11.2012
BG21.02.2013
NO21.02.2013
GR22.02.2013
ES04.03.2013
PT21.03.2013
Former [2013/31]AT21.11.2012
BE21.11.2012
FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
SI21.11.2012
NO21.02.2013
GR22.02.2013
ES04.03.2013
PT21.03.2013
Former [2013/28]BE21.11.2012
FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
SI21.11.2012
NO21.02.2013
GR22.02.2013
ES04.03.2013
PT21.03.2013
Former [2013/27]BE21.11.2012
FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
SI21.11.2012
NO21.02.2013
GR22.02.2013
ES04.03.2013
Former [2013/26]FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
SI21.11.2012
NO21.02.2013
GR22.02.2013
ES04.03.2013
Former [2013/24]FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
NO21.02.2013
GR22.02.2013
ES04.03.2013
Former [2013/23]FI21.11.2012
LT21.11.2012
LV21.11.2012
PL21.11.2012
NO21.02.2013
ES04.03.2013
Former [2013/22]FI21.11.2012
LT21.11.2012
NO21.02.2013
ES04.03.2013
Former [2013/20]LT21.11.2012
NO21.02.2013
Cited inInternational search[XA]WO2007027906  (CELL SIGNALING TECHNOLOGY INC [US], et al) [X] 70-72,81-87,89 * the whole document, in particular sequence 205; page 36, line 27 to page 38, line 1; claim 17 * [A] 73,74,88,90;
 [XA]WO2007084485  (BATTELLE MEMORIAL INSTITUTE [US], et al) [X] 70,81-86 * the whole document, in particular sequence 90; table 20; paragraph [0132]; claims 1, 58 * [A] 87-90;
 [XP]WO2009102261  (ATLAS ANTIBODIES AB [SE], et al) [XP] 70,71,81-90* the whole document, in particular sequences 4 and 5; page 53, line 32 to page 59, line 8; page 69, line 34 to page 70, line 22; claims 46-52 *;
 [A]  - RICHIE ET AL, "OCT4 Staining in Testicular Tumors. A Sensitive and Specific Marker for Seminoma and Embryonal Carcinoma", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US LNKD- DOI:10.1016/S0022-5347(01)68313-7, vol. 174, no. 2, ISSN 0022-5347, (20050801), pages 569 - 570, (20050801), XP025378158 [A] 1-6,19-43,45-69 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0022-5347(01)68313-7
 [A]  - PRICE P ET AL, "The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time-II. Prognostic significance in patients treated by chemotherapy", EUROPEAN JOURNAL OF CANCER AND CLINICAL ONCOLOGY, OXFORD, GB LNKD- DOI:10.1016/0277-5379(90)90015-L, (19900401), vol. 26, no. 4, pages 453 - 457, XP026204182 [A] 7-42,44-69 * the whole document *

DOI:   http://dx.doi.org/10.1016/0277-5379(90)90015-L
 [X]  - SLOOTSTRA J W ET AL, "STRUCTURAL ASPECTS OF ANTIBODY-ANTIGEN INTERACTION REVEALED THROUGH SMALL RANDOM PEPTIDE LIBRARIES", MOL DIVERS, (19950101), vol. 1, no. 2, pages 87 - 96, XP008065429 [X] 70-72,74 * the whole document, in particular abstract; page 89, column 1, lines 15-22; figures 2-4 *
 [XA]  - DANNO S ET AL, "Decreased expression of mouse Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis", AM J PATHOL, (20000501), vol. 156, no. 5, pages 1685 - 1692, XP002486927 [X] 81-85 * the whole document, in particular paragraph "Western Blot Analysis" on page 1686 * [A] 43-69,86-90
 [A]  - NILSSON P ET AL, "Towards a human proteome atlas: High-throughput generation of mono-specific antibodies for tissue profiling", PROTEOMICS, (20051101), vol. 5, pages 4327 - 4337, XP002572261 [A] 87-90 * the whole document *

DOI:   http://dx.doi.org/10.1002/PMIC.200500072
by applicantWO0104144
 WO0105808
    - RHODES ET AL., THE BIOMEDICAL SCIENTIST, (2006), pages 515 - 520
    - THOMPSON, J.D.; HIGGINS, D.G.; GIBSON, T.J., NUCLEIC ACIDS RESEARCH, (1994), vol. 22, pages 4673 - 4680
    - NILSSON P ET AL., PROTEOMICS, (2005), vol. 5, pages 4327 - 4337
    - K6HLER G; MILSTEIN C, EUR. J. IMMUNOL., (1976), vol. 6, pages 511 - 519
    - SKERRA A; P UCKTHUN A, SCIENCE, (1988), vol. 240, pages 1038 - 1041
    - BIRD RE; WALKER BW, TRENDS BIOTECHNOL., (1991), vol. 9, pages 132 - 137
    - STEVENS FJ ET AL., BIOCHEMISTRY, (1991), vol. 30, pages 6803 - 6805
    - HAMERS-CASTERMAN C ET AL., NATURE, (1993), vol. 363, pages 446 - 448
    - CAI X; GAREN A, PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, pages 6280 - 6285
    - MASAT L ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1994), vol. 91, pages 893 - 896
    - DOOLEY H ET AL., MOL. IMMUNOL., (2003), vol. 40, pages 25 - 33
    - BRADBURY AR; MARKS JD, J. IMMUNOL. METHS., (2004), vol. 290, pages 29 - 49
    - NYGREN PA; SKERRA A, J. IMMUNOL. METHS., (2004), vol. 290, pages 3 - 28
    - GOLD L ET AL., ANNU. REV. BIOCHEM., (1995), vol. 64, pages 763 - 797
    - NORD K ET AL., NAT. BIOTECHNOL., (1997), vol. 15, pages 772 - 777
    - BESTE G ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1999), vol. 96, pages 1898 - 1903
    - BINZ HK ET AL., J. MOL. BIOL., (2003), vol. 332, pages 489 - 503
    - SMITH GP ET AL., J. MOL. BIOL., (1998), vol. 277, pages 317 - 332
    - LEHTI6 ET AL., PROTEINS, (2000), vol. 41, pages 316 - 322
    - PEELLE B ET AL., CHEM. BIOL., (2001), vol. 8, pages 521 - 534
    - HUFTON SE ET AL., FEBS LETT., (2000), vol. 475, pages 225 - 231
    - IRVING RA ET AL., J. IMMUNOL. METH., (2001), vol. 248, pages 31 - 45
    - WENTZEL A ET AL., J. BACTERIOL., (2001), vol. 183, pages 7273 - 7284
    - BAGGIO R ET AL., J. MOL. RECOGNIT., (2002), vol. 15, pages 126 - 134
    - ROBERTS BL ET AL., GENE, (1992), vol. 121, pages 9 - 15
    - DENNIS MS; LAZARUS RA, J. BIOL. CHEM., (1994), vol. 269, pages 22137 - 22144
    - SCHNEIDER S ET AL., NAT. BIOTECHNOL., (1999), vol. 17, pages 170 - 175
    - LU Z ET AL., BIOTECHNOLOGY, (1995), vol. 13, pages 366 - 372
    - KLEVENZ B ET AL., CELL. MOL. LIFE SCI., (2002), vol. 59, pages 1993 - 1998
    - NORMAN TC ET AL., SCIENCE, (1999), vol. 285, pages 591 - 595
    - MCCONELL SJ; HOESS RH, J. MOL. BIOL., (1995), vol. 250, pages 460 - 479
    - LI R ET AL., PROTEIN ENG., (2003), vol. 16, pages 65 - 72
    - KOIDE A ET AL., J. MOL. BIOL., (1998), vol. 284, pages 1141 - 1151
    - XU L ET AL., CHEM. BIOL., (2002), vol. 9, pages 933 - 942
    - BIANCHI E ET AL., J. MOL. BIOL., (1995), vol. 247, pages 154 - 160
    - KLUG A, J. MOL. BIOL., (1999), vol. 293, pages 215 - 218
    - SEGAL DJ ET AL., BIOCHEMISTRY, (2003), vol. 42, pages 2137 - 2148
    - ELLINGTON AD; SZOSTAK JW, NATURE, (1990), vol. 346, pages 818 - 822
    - BRODY EN; GOLD L, J. BIOTECHNOL., (2000), vol. 74, pages 5 - 13
    - MAYER G; JENNE A, BIODRUGS, (2004), vol. 18, pages 351 - 359
    - SMITH GP, SCIENCE, (1985), vol. 228, pages 1315 - 1317
    - HANES J; P UCKTHUN A, PROC. NATL. ACAD. SCI. U.S.A., (1997), vol. 94, pages 4937 - 4942
    - FIELDS S; SONG 0, NATURE, (1989), vol. 340, pages 245 - 246
    - GAI SA; WITTRUP KD, CURR OPIN STRUCT BIOL, (2007), vol. 17, pages 467 - 473
    - ROBERTS RW; SZOSTAK JW, PROC. NATL. ACAD. SCI. U.S.A., (1997), vol. 94, pages 12297 - 12302
    - DAUGHERTY PS, CURR OPIN STRUCT BIOL, (2007), vol. 17, pages 474 - 480
    - KRONQVIST N ET AL., PROTEIN ENG DES SEL, (2008), pages 1 - 9
    - HARVEY BR ET AL., PNAS, (2004), vol. 101, no. 25, pages 913 - 9198
    - NORD 0 ET AL., J BIOTECHNOL, (2003), vol. 106, pages 1 - 13
    - TUERK C; GOLD L, SCIENCE, (1990), vol. 249, pages 505 - 510
    - REMY I; MICHNICK SW, PROC. NATL. ACAD. SCI. U.S.A., (1999), vol. 96, pages 5394 - 5399
    - STRYER L, SCIENCE, (1968), vol. 162, pages 526 - 533
    - BRAND L; GOHLKE JR, ANNU. REV. BIOCHEM., (1972), vol. 41, pages 843 - 868
    - CHAN ET AL., CURR OPI BIOTECH., (2002), vol. 13, pages 40 - 46
    - WENSEL TG; MEARES CF, Radioimmunoimaging and Radioimmunotherapy, ELSEVIER, (1983), pages 185 - 196
    - LINDSKOG M ET AL., BIOTECHNIQUES, (2005), vol. 38, pages 723 - 727
    - LARSSON M ET AL., J. BIOTECHNOL., (2000), vol. 80, pages 143 - 157
    - SJÖLANDER A ET AL., J. IMMUNOL. METHODS, (1999), vol. 201, pages 115 - 123
    - STAH S ET AL., Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis and Bioseparation, JOHN WILEY AND SONS INC., (1998), pages 49 - 63
    - STEEN J ET AL., PROTEIN EXPR. PURIF., (2006), vol. 46, pages 173 - 178
    - AGATON C ET AL., J. CHROMATOGR. A, (2004), vol. 1043, pages 33 - 40
    - L6FBLOM, J ET AL., FEMS MICROBIOL LETT, (2005), vol. 248, pages 189 - 198
    - LARSSON ET AL., J IMMUNOL METHODS 15, (2009), vol. 34, no. 1-2, pages 20 - 32
    - SCHWENK ET AL., MOL CELL PROTEOMICS, (2007), vol. 6, no. 1, pages 125 - 32
    - ALLRED ET AL., MOD PATHOL, (1998), vol. 11, no. 2, page 155
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.